Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Leveraging Extended Families for Cardiovascular Disease Genomic Discovery

ABSTRACT: Leveraging Extended Families for Cardiovascular Disease Genomic Discovery

PROVIDER: PRJNA737008 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Leveraging Extended Families for Cardiovascular Disease Genomic Discovery

Project description:Leveraging Extended Families for Cardiovascular Disease Genomic Discovery

| PRJNA737009 | ENA

Next generation rare variant discovery in multiplex AD families

Project description:Next generation rare variant discovery in multiplex AD families

| PRJNA517199 | ENA

Next generation rare variant discovery in multiplex AD families

Project description:Next generation rare variant discovery in multiplex AD families

| PRJNA517200 | ENA

Discovery of colorectal cancer susceptibility genes in high-risk families

Project description:Discovery of colorectal cancer susceptibility genes in high-risk families

| PRJNA523458 | ENA

Discovery of colorectal cancer susceptibility genes in high-risk families

Project description:Discovery of colorectal cancer susceptibility genes in high-risk families

| PRJNA523459 | ENA

Center for Common Disease Genomics [CCDG] - Cardiovascular: Cardiology Biobanking for Biomarker Discovery

Project description:Center for Common Disease Genomics [CCDG] - Cardiovascular: Cardiology Biobanking for Biomarker Discovery

| PRJNA787356 | ENA

Center for Common Disease Genomics [CCDG] - Cardiovascular: Cardiology Biobanking for Biomarker Discovery

Project description:Center for Common Disease Genomics [CCDG] - Cardiovascular: Cardiology Biobanking for Biomarker Discovery

| PRJNA787357 | ENA

Extended Primate aCGH

Project description:Extended Primate aCGH

| PRJNA102527 | ENA

Identification of truncating mutations in HPCX1 families with NMD technology

Project description:In this study, nonsense-mediated mRNA decay (NMD) inhibition was used for the discovery of truncating mutations. Six prostate cancer (PRCA) patients and their healthy brothers were selected from a group of HPCX1-linked families. mRNA was isolated from their lymphoblastic cells after pharmacological treatment. Expression analyses were done using Agilent 44K oligoarrays, and selected genes were screened for mutations by sequencing.

2011-12-31 | GSE24204 | GEO